Related posts

BoC cuts again, but markets flatStocks slide on hawkish Fed commentsMarkets pause, awaiting earnings
Investor Insights

This summary was created by AI, based on 13 opinions in the last 12 months.

Mondelez International Inc. (MDLZ) is facing challenges related to growth and valuation, as various analysts highlight concerns over economic uncertainties and consumer spending patterns. With a valuation over 20x PE and modest earnings growth projected at around 5%, some experts express hesitancy toward investing further in the stock, favoring alternatives like Lindt or more stable consumer staples. However, there are optimistic views on MDLZ's strong brand presence and historical ability to pass on costs to consumers, along with the potential for a solid dividend yield. The impact of rising cocoa prices and a strong USD on international revenue are noted as significant headwinds affecting the company's future performance. Despite these challenges, some analysts maintain a long-term bullish outlook, given its market dominance in biscuits and chocolates, and believe it can achieve steady growth of 3%-5% over the longer term.

Consensus
Mixed
Valuation
Fair Value
DON'T BUY

Buying Hershey's will be a large purchase for them. MDLZ is attractively priced, but he wouldn't buy. He prefers Lindt, which has outperformed. But he likes staples at this part of the cycle.

DON'T BUY

Biggest issue is growth. Well run, amazing brands. Valuation north of 20x, yet growth profile not as robust. Economic uncertainty, bit of weakness in discretionary spending.

DON'T BUY

These companies have traded off on the fears of GLP-1. Volumes starting to drop. Growth metrics just don't support the valuations in the space. About 60% of revenue from international sources, so strong USD is a major headwind.

DON'T BUY

Trades at 18x PE, with 5% growth. He likes growth at a reasonable price, so 5% doesn't cut it. Stock's moved below 200-day MA, which is falling. Short-term technicals look weak. Demand for GLP-1 drugs will impact a lot of companies in the food business.

PAST TOP PICK
(A Top Pick Oct 30/23, Up 2%)

Limited private-label competition. During pandemic, good at passing cost increases along to consumers without demand falling off. Concerns about impact of weight-loss drugs has abated. But huge increase in cocoa prices, at 47-year highs. Still happy to own.

COMMENT

It is a large consumer products company and has gone though re-structuring. Pays a rock solid dividend. Although high quality it is low growth so he sees better better value in the field.

DON'T BUY

International snack giant. 200-day MA is sideways to slightly negative, stock price is now below it. Fundamentals show only mid-single-digit earnings growth, paying 20x for it. Cost pressures, margin compression. Intense competition. Foreign currency has not helped.

For a consumer staples name, look at Loblaw or COST.

BUY

Owns shares and would recommend buying. Global consumer goods powerhouse. Strong brand names with sticky adoption rates. Ability to generate profits despite higher chocolate prices. Would recommend holding for the long term. Ability to pass on rising costs to consumers. 

BUY

Still likes it. Concern now is that with higher interest rates and rising unemployment, consumers are being more price-conscious. Company has acknowledged this in its biscuit category. 

Reassessing pricing and packaging. EMs are about 40% of sales, she sees higher growth there. Selling assets, redeploying proceeds in higher-growth adjacent categories.

HOLD
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

Nothing much has changed in MDLZ’s fundamentals over the years, except the valuation has gone down and it is now trading at 18.8x times' Forward P/E ( a fair valuation given MDLZ consistently has traded above 20x). The leverage level has gone down meaningfully in recent years, and the net debt/EBITDA level is now at 1.9x, the lowest in years, indicating a capacity for raising dividends or buying back shares. The company has been a predictable grower, and we think MDLZ would be comfortable to grow 3%-5% for a very long time, it is an attractive dividend grower over time, but the business is mature and fairly low growth overall. We would be OK owning it for income but otherwise do not see it as overly interesting. 
Unlock Premium - Try 5i Free

DON'T BUY

Good company, but now up against weight-loss drugs. Makes the core thesis tough. High cocoa prices increased input prices. Lots of international sales, so a strong USD is not constructive.

PAST TOP PICK
(A Top Pick Oct 20/23, Up 8%)

At the time of this pick, GLP weight-loss drugs were creating overhang on the stock. Very well run. Great presence internationally. Recent quarter underwhelming, lower-income US consumer starting to get pressured. Happy to hold due to market dominance and attractive valuation.

TOP PICK

A leader in biscuits and chocolate, with very little private label competition. Very strong brand loyalty. Innovating and acquiring. Disposing of lower-growth areas such as gum. Likes the topline growth, as well as incremental margin growth. Decent yield of 2.4%.

(Analysts’ price target is $83.44)
DON'T BUY

Return on capital inconsistent and low. Free cash flow also not too high. Insider ownership also unclear. Food and beverage hard to compete with if company has a strong moat. Unclear on future of business. Better options for investors in the markets. 

BUY

Owns shares and believes in prospects of business. Chocolate business very strong. "Snack business" also growing at high rate. Able to pass on costs to consumers. Brand loyalty continues to grown. Strong array of products. Stable business that is good for defensive investors. 

Showing 1 to 15 of 115 entries

MONDELEZ INTERNATIONAL INC Common Stock(MDLZ-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 6

Total Signals / Votes : 11

Stockchase rating for MONDELEZ INTERNATIONAL INC Common Stock is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

MONDELEZ INTERNATIONAL INC Common Stock(MDLZ-Q) Frequently Asked Questions

What is MONDELEZ INTERNATIONAL INC Common Stock stock symbol?

MONDELEZ INTERNATIONAL INC Common Stock is a American stock, trading under the symbol MDLZ-Q on the NASDAQ (MDLZ). It is usually referred to as NASDAQ:MDLZ or MDLZ-Q

Is MONDELEZ INTERNATIONAL INC Common Stock a buy or a sell?

In the last year, 11 stock analysts published opinions about MDLZ-Q. 4 analysts recommended to BUY the stock. 6 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for MONDELEZ INTERNATIONAL INC Common Stock.

Is MONDELEZ INTERNATIONAL INC Common Stock a good investment or a top pick?

MONDELEZ INTERNATIONAL INC Common Stock was recommended as a Top Pick by on . Read the latest stock experts ratings for MONDELEZ INTERNATIONAL INC Common Stock.

Why is MONDELEZ INTERNATIONAL INC Common Stock stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is MONDELEZ INTERNATIONAL INC Common Stock worth watching?

11 stock analysts on Stockchase covered MONDELEZ INTERNATIONAL INC Common Stock In the last year. It is a trending stock that is worth watching.

What is MONDELEZ INTERNATIONAL INC Common Stock stock price?

On 2025-03-13, MONDELEZ INTERNATIONAL INC Common Stock (MDLZ-Q) stock closed at a price of $64.69.